INNOVATIVE SOLTNS & SUPP ($ISSC) posted quarterly earnings results for Q1 2026 on Thursday, February 12th. The company reported earnings of $0.25 per share, beating estimates of $0.10 by $0.15. The company also reported revenue of $21,810,000, beating estimates of $18,923,040 by $2,886,960.
You can see Quiver Quantitative's $ISSC stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
INNOVATIVE SOLTNS & SUPP Hedge Fund Activity
We have seen 52 institutional investors add shares of INNOVATIVE SOLTNS & SUPP stock to their portfolio, and 44 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CITADEL ADVISORS LLC added 217,498 shares (+301.7%) to their portfolio in Q3 2025, for an estimated $2,716,550
- MARSHALL WACE, LLP added 189,375 shares (+65.3%) to their portfolio in Q3 2025, for an estimated $2,365,293
- SUSQUEHANNA INTERNATIONAL GROUP, LLP added 177,240 shares (+440.0%) to their portfolio in Q3 2025, for an estimated $2,213,727
- WEALTHTRUST AXIOM LLC removed 151,567 shares (-31.9%) from their portfolio in Q3 2025, for an estimated $1,893,071
- RENAISSANCE TECHNOLOGIES LLC removed 142,800 shares (-30.4%) from their portfolio in Q3 2025, for an estimated $1,783,572
- VANGUARD GROUP INC added 140,560 shares (+25.3%) to their portfolio in Q4 2025, for an estimated $2,662,206
- GOLDMAN SACHS GROUP INC added 103,806 shares (+703.6%) to their portfolio in Q4 2025, for an estimated $1,966,085
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
INNOVATIVE SOLTNS & SUPP Analyst Ratings
Wall Street analysts have issued reports on $ISSC in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Northland Capital Markets issued a "Outperform" rating on 11/21/2025
To track analyst ratings and price targets for INNOVATIVE SOLTNS & SUPP, check out Quiver Quantitative's $ISSC forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
